Rory B. Riggs

Insider Reports History

Entity
Individual
Location
65 Railroad Ave, Ridgefield, NJ
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rory B. Riggs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cibus, Inc. Chief Executive Officer, Director, 10%+ Owner Class A Common Stock 3.2M $32.7M $10.20 Jun 11, 2024 Direct
Cibus, Inc. Chief Executive Officer, Director, 10%+ Owner Cibus Common Units 1.37M $14.5M $10.58 Dec 29, 2023 Direct
Royalty Pharma plc Director Class A Ordinary Shares 320K $8.82M $27.55 Feb 20, 2024 Direct
Intra-Cellular Therapies, Inc. Director Common Stock 117K $8M $68.49 Jun 28, 2024 Direct
Royalty Pharma plc Director Class A Ordinary Shares 85.2K $2.35M $27.55 Feb 20, 2024 By New Ventures III LLC
Cibus, Inc. Chief Executive Officer, Director, 10%+ Owner Pre-Funded Warrant 50K $529K $10.57 Dec 12, 2023 Direct
FIBROGEN INC Director Common Stock 606K $460K $0.76 May 26, 2021 Indirect
Royalty Pharma plc Director Class A Ordinary Shares 15K $413K $27.55 Feb 20, 2024 By Spouse
FIBROGEN INC Director Common Stock 396K $301K $0.76 May 26, 2021 Direct
Cibus, Inc. Chief Executive Officer, Director, 10%+ Owner Cibus Common Units 20.9K $221K $10.58 Dec 29, 2023 Indirect
Cibus, Inc. Chief Executive Officer, Director, 10%+ Owner Class A Common Stock 15.8K $161K $10.20 Jun 11, 2024 By spouse
Cibus, Inc. Chief Executive Officer, Director, 10%+ Owner Class A Common Stock 2.92K $29.7K $10.20 Jun 11, 2024 Indirect
Intra-Cellular Therapies, Inc. Director Restricted Stock Units 0 $0 $76.07 Jun 23, 2024 Direct
Cibus, Inc. Chief Executive Officer, Director, 10%+ Owner Class B Common Stock 1.37M Dec 29, 2023 Direct
Royalty Pharma plc Director LP interests in RPI US Partners 2019, LP 270K Feb 20, 2024 Direct
Cibus, Inc. Chief Executive Officer, Director, 10%+ Owner Common Warrant 98K Jun 11, 2024 Direct
Cibus, Inc. Chief Executive Officer, Director, 10%+ Owner Class B Common Stock 20.9K Dec 29, 2023 Indirect
FIBROGEN INC Director Stock Option (Right to Buy) 7.8K May 26, 2021 Direct
Intra-Cellular Therapies, Inc. Director Stock Option (right to buy) 0 Jun 24, 2024 Direct

Insider Reports Filed by Rory B. Riggs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITCI Intra-Cellular Therapies, Inc. Jun 28, 2024 1 $17.9K 4 Jul 2, 2024 Director
ITCI Intra-Cellular Therapies, Inc. Jun 23, 2024 5 $6.66 4 Jun 25, 2024 Director
ITCI Intra-Cellular Therapies, Inc. Jun 14, 2024 2 $0 4 Jun 18, 2024 Director
CBUS Cibus, Inc. Jun 11, 2024 2 $1M 4 Jun 14, 2024 Chief Executive Officer, Director, 10%+ Owner
ITCI Intra-Cellular Therapies, Inc. Mar 31, 2024 1 $18K 4 Apr 2, 2024 Director
ITCI Intra-Cellular Therapies, Inc. Mar 20, 2024 2 $371K 4 Mar 22, 2024 Director
RPRX Royalty Pharma plc Feb 20, 2024 2 $0 4 Feb 22, 2024 Director
RPRX Royalty Pharma plc Jan 2, 2024 3 -$13.2M 4 Jan 4, 2024 Director
ITCI Intra-Cellular Therapies, Inc. Dec 31, 2023 1 $18K 4 Jan 3, 2024 Director
CBUS Cibus, Inc. Dec 29, 2023 5 $0 4 Jan 3, 2024 Chief Executive Officer, Director, 10%+ Owner
CBUS Cibus, Inc. Dec 12, 2023 3 $6M 4 Dec 14, 2023 Chief Executive Officer, Director, 10%+ Owner
RPRX Royalty Pharma plc Nov 13, 2023 2 $0 4 Nov 14, 2023 Director
ITCI Intra-Cellular Therapies, Inc. Sep 30, 2023 1 $18K 4 Oct 2, 2023 Director
RPRX Royalty Pharma plc Aug 8, 2023 1 $0 4 Aug 8, 2023 Director
ITCI Intra-Cellular Therapies, Inc. Jun 30, 2023 1 $17.7K 4 Jul 5, 2023 Director
ITCI Intra-Cellular Therapies, Inc. Jun 23, 2023 2 $0 4 Jun 27, 2023 Director
RPRX Royalty Pharma plc Jun 23, 2023 1 $0 4 Jun 26, 2023 Director
CBUS Cibus, Inc. May 31, 2023 0 $0 4/A Jun 15, 2023 Chief Executive Officer, Director, 10%+ Owner
CBUS Cibus, Inc. May 31, 2023 0 $0 3 Jun 2, 2023 Chief Executive Officer, Director
RPRX Royalty Pharma plc May 22, 2023 1 -$57.4M 4 May 22, 2023 Director
RPRX Royalty Pharma plc May 9, 2023 2 $0 4 May 12, 2023 Director
ITCI Intra-Cellular Therapies, Inc. Mar 31, 2023 1 $16.9K 4 Apr 4, 2023 Director
RPRX Royalty Pharma plc Mar 29, 2023 2 -$5.08M 4 Mar 30, 2023 Director
RPRX Royalty Pharma plc Feb 17, 2023 2 $0 4 Feb 17, 2023 Director
ITCI Intra-Cellular Therapies, Inc. Dec 30, 2022 1 $17K 4 Jan 3, 2023 Director
RPRX Royalty Pharma plc Dec 9, 2022 2 -$2.52M 4 Dec 13, 2022 Director
RPRX Royalty Pharma plc Nov 17, 2022 1 -$5.08M 4 Nov 21, 2022 Director
ITCI Intra-Cellular Therapies, Inc. Sep 30, 2022 1 $17K 4 Oct 4, 2022 Director
RPRX Royalty Pharma plc Sep 14, 2022 2 -$4.23M 4 Sep 15, 2022 Director
RPRX Royalty Pharma plc Aug 9, 2022 1 -$1.97M 4 Aug 11, 2022 Director
ITCI Intra-Cellular Therapies, Inc. Jun 30, 2022 1 $16.5K 4 Jul 5, 2022 Director
RPRX Royalty Pharma plc Jun 29, 2022 1 -$1.27M 4 Jun 29, 2022 Director
ITCI Intra-Cellular Therapies, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
RPRX Royalty Pharma plc May 19, 2022 2 -$5.91M 4 May 23, 2022 Director
ITCI Intra-Cellular Therapies, Inc. Mar 31, 2022 1 $15.7K 4 Apr 4, 2022 Director
RPRX Royalty Pharma plc Mar 29, 2022 1 -$2.32M 4 Mar 30, 2022 Director
RPRX Royalty Pharma plc Mar 17, 2022 10 -$6.67M 4 Mar 21, 2022 Director
ITCI Intra-Cellular Therapies, Inc. Mar 16, 2022 6 -$13.6M 4 Mar 18, 2022 Director
ITCI Intra-Cellular Therapies, Inc. Dec 31, 2021 1 $15.7K 4 Jan 4, 2022 Director
RPRX Royalty Pharma plc Dec 28, 2021 9 -$7.4M 4 Dec 30, 2021 Director
RPRX Royalty Pharma plc Nov 16, 2021 10 -$9.08M 4 Nov 18, 2021 Director
ITCI Intra-Cellular Therapies, Inc. Sep 30, 2021 1 $15.7K 4 Oct 4, 2021 Director
RPRX Royalty Pharma plc Sep 28, 2021 12 -$4.69M 4 Sep 30, 2021 Director
ITCI Intra-Cellular Therapies, Inc. Jun 30, 2021 1 $15.7K 4 Jul 2, 2021 Director
RPRX Royalty Pharma plc Jun 25, 2021 5 -$55.4M 4 Jun 29, 2021 Director
ITCI Intra-Cellular Therapies, Inc. Jun 21, 2021 1 $0 4 Jun 22, 2021 Director
RPRX Royalty Pharma plc Jun 7, 2021 1 $12.4M 4 Jun 8, 2021 Director
ITCI Intra-Cellular Therapies, Inc. May 27, 2021 2 $0 4 Jun 4, 2021 Director
FGEN FIBROGEN INC May 26, 2021 2 $0 4 May 28, 2021 Director
RPRX Royalty Pharma plc May 7, 2021 4 $0 4 May 11, 2021 Director